First-In-Human Study in Cancer Patients Establishing the Feasibility of Oxygen Measurements in Tumors Using Electron Paramagnetic Resonance With the OxyChip

OBJECTIVE: The overall objective of this clinical study was to validate an implantable oxygen sensor, called the ‘OxyChip’, as a clinically feasible technology that would allow individualized tumor-oxygen assessments in cancer patients prior to and during hypoxia-modification interventions such as h...

Descripción completa

Detalles Bibliográficos
Autores principales: Schaner, Philip E., Williams, Benjamin B., Chen, Eunice Y., Pettus, Jason R., Schreiber, Wilson A., Kmiec, Maciej M., Jarvis, Lesley A., Pastel, David A., Zuurbier, Rebecca A., DiFlorio-Alexander, Roberta M., Paydarfar, Joseph A., Gosselin, Benoit J., Barth, Richard J., Rosenkranz, Kari M., Petryakov, Sergey V., Hou, Huagang, Tse, Dan, Pletnev, Alexandre, Flood, Ann Barry, Wood, Victoria A., Hebert, Kendra A., Mosher, Robyn E., Demidenko, Eugene, Swartz, Harold M., Kuppusamy, Periannan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8517507/
https://www.ncbi.nlm.nih.gov/pubmed/34660306
http://dx.doi.org/10.3389/fonc.2021.743256

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8517507/
https://www.ncbi.nlm.nih.gov/pubmed/34660306
http://dx.doi.org/10.3389/fonc.2021.743256

Ejemplares similares